title: Acetate-free biofiltration for acute renal failure.
abstract: The characteristics of acetate-free biofiltration (AFB) are now well documented in patients with chronic renal failure: hemodynamic tolerance, correction of acid-base imbalance, buffer-free dialysate (without acetate) and absence of backfiltration. This hemodialysis technique can be beneficial to patients with acute renal failure (ARF). In our intensive care unit, we prospectively studied 29 patients with isolated ARF or ARF associated with failure of other organs. All eligible patients were randomly assigned to undergo dialysis with bicarbonate hemodialysis (BH) or with (AFB). All used the same high flux biocompatible dialysis membranes. Effectiveness and hemodynamic tolerance of hemodialysis sessions and evolution of patients were analyzed. Correction of metabolic disorders, although better in the AFB group was not statistically different from that in the BH group. Re-equilibration of acid-base balance was also similar, with or without mechanical ventilation. Heparin consumption was significantly higher in the AFB group, with no effect on haemorrhagic complications. Analysis of hypo- and hypertensive episodes, defined as arterial pressure (AP) variations 20% greater than initial pressure, showed no difference in terms of number or degree of AP variation. However, weight loss and the rate of ultrafiltration led to a higher hypotensive risk in the BH group (p < 0.05). Finally, the clinical course and prognosis was similar in both groups. In summary, AFB may be considered as effective a hemodialysis technique as BH in patients with ARF. Weight loss was better tolerated in the AFB group and can be a favorable factor considering the deleterious effect of overhydration in patients admitted to an intensive care unit. This study invites a comparison of longer dialysis session of AFB therapy and continuous hemodiafiltration.
authors.affiliation: Department of Nephrology, Hôpital Edouard Herriot, Lyon, France.
authors.forename: M
authors.initials: M
authors.lastname: Bret
authors.forename: J M
authors.initials: JM
authors.lastname: Hurot
authors.forename: A
authors.initials: A
authors.lastname: Mercatello
authors.forename: B
authors.initials: B
authors.lastname: Coronel
authors.forename: D
authors.initials: D
authors.lastname: Dorez
authors.forename: M
authors.initials: M
authors.lastname: Laville
authors.forename: J F
authors.initials: JF
authors.lastname: Moskovtchenko
mesh_terms: D000136:Acid-Base Equilibrium; D058186:Acute Kidney Injury / Q000628:therapy*; D001639:Bicarbonates; D005260:Female; D017583:Hemodiafiltration; D006801:Humans; D008297:Male; D008567:Membranes, Artificial; D008875:Middle Aged; D011446:Prospective Studies; D006435:Renal Dialysis; D015431:Weight Loss
chemical_list: D001639:Bicarbonates; D008567:Membranes, Artificial